233980 Implementation of Health Care Reform: Optimizing Reform for Women's Health

Monday, November 8, 2010 : 3:10 PM - 3:30 PM

Judy Waxman, JD , Health and Reproductive Rights, National Women's Law Center, Washington, DC
           
Reproductive health care is basic health care for women. Yet many women lack access to the health care services, information, and social supports they need to stay healthy and to make healthy decisions for themselves and their families. The purpose of this presentation is to highlight and discuss key issues related to the implementation of ACA, implications of this new law for women's health, and recommendations for optimizing ACA. These provisions have a direct impact on women's reproductive health, and largely for the good—by improving access to health insurance coverage for maternity care and family planning services, making it easier for states to expand Medicaid coverage of family planning, investing in comprehensive sex education, and more.

Learning Areas:
Provision of health care to the public
Public health or related laws, regulations, standards, or guidelines

Learning Objectives:
As a result of this presentation, participants will be able to describe key issues regarding implementation of ACA, implications for women’s health and recommendations for optimizing ACA.

Keywords: Health Reform, Health Care Reform

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Vice President of Health and Reproductive Rights at the National Women's Law Center. She pioneers advocacy, policy and educational strategies to promote the quality and availability of health care, including reproductive choice, for American women. Prior to joining the National Women's Law Center, Ms. Waxman served as Deputy Executive Director at Families USA for over a decade.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3329.0: Martha May Eliot Forum: Implementing Health Reform